PCR BIO SYSTEMS LIMITEDActive
Key figures
PCR BIO SYSTEMS LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024/25Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £100,000.
Filed accounts2020/21–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Profit for the year | — | 4,705,042 | 169,980 | -833,091 | -408,205 |
| Cash at bank and in hand | 6,730,149 | 4,043,736 | 3,025,471 | 1,710,019 | 1,382,223 |
| Total assets | 10,240,529 | 7,310,949 | 6,706,011 | 5,379,327 | 4,885,451 |
| Total liabilities | 3,832,888 | — | 903,530 | 692,619 | — |
| Net assets / total equity | 6,328,507 | 6,133,779 | 5,626,231 | 4,643,764 | 4,135,559 |
| Average number of employees | 27 | 29 | 32 | 31 | 0 |
| Average pay (per year) | — | 42,099 | 43,026 | — | — |
| Dividends paid | — | — | 337,568 | 149,376 | 100,000 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: PCR BIO SYSTEMS LIMITED
Company
PCR BIO SYSTEMS LIMITED is a private limited company registered with Companies House under company number 07960612. It was incorporated on 22 Feb 2012. Its status is active. The registered office is in London (N6). Its nature of business (SIC 2007) is manufacture of other chemical products n.e.c. (20590).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Loss for the year was £408,205. Net assets were £4,135,559, down 10.9% on the previous year. Cash at bank and in hand was £1,382,223. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2024/25).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 8 Mar 2027.